Randomized clinical trial to compare the efficacy of self-expanding bare metal nitinol stent and balloon angioplasty alone for below-the-knee lesions following successful balloon angioplasty: 1-year clinical outcomes.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 12 08 2023
accepted: 23 10 2023
medline: 15 11 2023
pubmed: 13 11 2023
entrez: 13 11 2023
Statut: epublish

Résumé

This prospective, multicenter, randomized study aimed to compare the 1-year clinical outcomes after primary stenting with self-expanding bare metal nitinol stent (SENS) and plain old balloon angioplasty (POBA) in patients with critical limb ischemia (CLI) and below-the-knee (BTK) lesions. Overall, 119 patients with CLI and BTK lesions were randomized to POBA alone (POBA group, 61 patients) or primary stenting with SENS (stenting group, 58 patients) after achieving acceptable POBA results in target BTK lesions. Clinical outcomes including amputation and revascularization rates were prospectively compared for 1 year. After 1 year, similar incidence rates of individual clinical endpoints, including cardiac death (6.5% vs. 5.1%, p > 0.999), myocardial infarction (1.6% vs. 0.0%, p > 0.999), repeat revascularization (19.6% vs. 18.9%, p = 0.922), target lesion revascularization (13.1% vs. 17.2%, p = 0.530), and amputation (4.9% vs. 0.0%, p = 0.244), were observed. POBA appeared to have acceptable treatment outcomes compared with primary stenting with SENS after 1 year in CLI patients with BTK lesions undergoing percutaneous transluminal angioplasty (PTA).

Identifiants

pubmed: 37956128
doi: 10.1371/journal.pone.0294132
pii: PONE-D-23-24607
pmc: PMC10642822
doi:

Substances chimiques

nitinol 2EWL73IJ7F

Types de publication

Randomized Controlled Trial Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0294132

Informations de copyright

Copyright: © 2023 Ahn et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Endovasc Ther. 2015 Oct;22(5):690-7
pubmed: 26245919
Eur Radiol. 2004 Feb;14(2):292-301
pubmed: 12955452
J R Soc Med. 2017 Mar;110(3):104-109
pubmed: 28116957
J Vasc Surg. 2006 Apr;43(4):742-751; discussion 751
pubmed: 16616230
J Vasc Surg. 2008 May;47(5):975-981
pubmed: 18372148
Semin Intervent Radiol. 2014 Dec;31(4):378-88
pubmed: 25435665
J Clin Med. 2020 Oct 16;9(10):
pubmed: 33081117
Circ Cardiovasc Interv. 2010 Jun 1;3(3):267-76
pubmed: 20484101
J Vasc Surg. 2010 Aug;52(2):356-61
pubmed: 20541349
J Vasc Surg. 2007 Jan;45 Suppl S:S5-67
pubmed: 17223489
Cochrane Database Syst Rev. 2018 Dec 08;12:CD009195
pubmed: 30536919
Radiology. 2011 Nov;261(2):634-42
pubmed: 22012905
J Vasc Interv Radiol. 2000 Sep;11(8):1021-31
pubmed: 10997465
Catheter Cardiovasc Interv. 2010 Dec 1;76(7):1047-54
pubmed: 20518006
Can J Cardiol. 2022 May;38(5):560-587
pubmed: 35537813
J Vasc Interv Radiol. 2007 Jun;18(6):703-8
pubmed: 17538131
J Cardiovasc Surg (Torino). 2016 Oct;57(5):653-66
pubmed: 27177357
Cardiovasc Diabetol. 2017 Apr 4;16(1):41
pubmed: 28376797
J Interv Cardiol. 2013 Aug;26(4):319-24
pubmed: 23795656
J Vasc Surg. 2006 Jun;43(6):1183-90
pubmed: 16765235
J Cardiovasc Surg (Torino). 2007 Aug;48(4):455-61
pubmed: 17653005
J Vasc Surg. 2014 Jan;59(1):220-34.e1-2
pubmed: 24126108
N Engl J Med. 2006 May 4;354(18):1879-88
pubmed: 16672699
Lancet. 2005 Dec 3;366(9501):1925-34
pubmed: 16325694
Eur J Radiol. 2010 Jul;75(1):37-42
pubmed: 20462719
Catheter Cardiovasc Interv. 2012 Nov 15;80(6):1042-51
pubmed: 22605682
J Vasc Surg. 2007 Feb;45(2):304-10; discussion 310-1
pubmed: 17264008
Trials. 2017 Dec 14;18(1):594
pubmed: 29237489
PLoS One. 2021 Jun 10;16(6):e0251755
pubmed: 34111147

Auteurs

Jihun Ahn (J)

Department of Internal Medicine, Daejeon Eulji Medical Center, Eulji University School of Medicine, Daejeon, Korea.

HyeYon Yu (H)

School of Nursing, College of Medicine, Soonchunhyang University, Asan, Korea.

Seung-Woon Rha (SW)

Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.

Byoung Geol Choi (BG)

Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.

Dong Oh Kang (DO)

Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.

Cheol Ung Choi (CU)

Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.

Sangho Park (S)

Department of Internal Medicine, Soonchunhyang University Hospital, Cheonan, Korea.

Jon Seo (J)

Department of Internal Medicine, Soonchunhyang University Hospital, Bucheon, Korea.

Kichang Kim (K)

Department of Internal Medicine, Shihwa General Hospital, Siheung, Korea.

Minung Kim (M)

Department of Internal Medicine, Changwon Hanmaeum Hospital, Changwon, Korea.

Yong Hoon Kim (YH)

Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, Korea.

Yong Seong Seo (YS)

Department of Internal Medicine, Myongji Hospital, Goyang, Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH